Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 710-715

  Repp, Amanda C ^a   Mayhew, Elizabeth S ^a   Apte, Sherine ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE MIGRATION INHIBITION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; UVEA MELANOMA;

EID: 0034661868     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.710     Document Type: Article

References (42)

1. Albert, D. M., A. S. Niffenegger, and J. K. V. Willson. 1992. Treatment of metastatic uveal melanoma: review and recommendations. Surv. Ophthalmol. 36:429.
2. Streilein, J. W. 1993, Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5:428.
3. Niederkorn, J. Y. 1999. Anterior chamber-associated immune deviation. Chem. Immunol., 73:59.
4. Wenkel, H., and J. W. Streilein. 1998. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest. Ophthalmol. Vis. Sci. 39:1823.
5. Wenkel, H., Chen, P. W., Ksander, B. R., and J. W. Streilein. 1999. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space. Invest. Ophthalmol. Vis. Sci. 40:3202.
6. Jiang, L. Q., Jorquera, M., and J. W. Streilein. 1993. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest. Ophthalmol. Vis. Sci. 34:3347.
7. Streilein, J. W., and D. Bradley. 1991. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest. Opthalmol. Vis. Sci. 32:2700.
8. Kaiser, C. J., B. R. Ksander, and J. W. Streilein. 1989. Inhibition of lymphocyte proliferation by aqueous humor. Regul. Immunol. 2:42.
9. Streilein, J. W., and S. W Cousins. 1990. Aqueous humor factors and their effect on the immune response in the anterior chamber. Curr. Eye Res. 9(Suppl):175.
10. Knisely, T. L., J. Hosoi, R. Nazareno, and R. D. Granstein. 1994. The presence of biologically significant concentrations of glucocorticoids but little or no cortisol binding globulin within aqueous humor: relevance to immune privilege in the anterior chamber of the eye. Invest. Ophthalmol. Vis. Sci. 35:3711.
11. Taylor, A. W., J. W. Streilein, and S. W. Cousins. 1992. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11:1199.
12. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
13. Fujikawa, L. S., R. B. Colvin, A. K. Bhan, T. C. Fuller, and S. Foster. 1982. Expression of HLA-A/B/C and -DR locus antigens on epithelial, stromal, and endothelial cells of the human cornea. Cornea 1:213.
14. Apte, R. S., and J. Y. Niederkorn. 1996. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J. Immunol. 156:2667.
15. Apte, R. S., D. Sinha, E. Mayhew, G. J. Wistow, and J. Y. Niederkorn. 1998. Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J. Immunol. 160:5693.
16. Apte, R. S., E. Mayhew, and J. Y. Niederkorn. 1997. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest. Ophthalmol. Vis. Sci. 38:1277.
17. Ma, D., G. P. Luyten, T. M. Luider, and J. Y. Niederkorn. 1995. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest. Ophthalmol. Vis. Sci. 36:435.
18. Wistow, G., Shagnessy, M. P., Lee, D. C., Hodin, J., and P. S. Zelenka. 1993. A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc. Natl. Acad. Sci. USA 90:1272.
19. Matsuda, A., Kotake, S., Tagawa, Y., Matsuda, H., and J. Nishihira. 1996. Detection and localization of macrophage migration inhibitory factor in rat iris and ciliary epithelium, Immunol. Lett. 53:1.
20. Matsuda, A., Tagawa, Y., Yoshida, K., Matsuda, H., and J. Hishihira. 1997. Expression of macrophage migration inhibitory factor in rat retina and its immunohistochemical localization. J. Neuroimmunol. 77:85.
21. Matsuda, A., Tagawa, Y., Matsuda, H., and J. Nishihira. 1996. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human corneas. FEBS Lett. 385:225.
22. Tzung, S.-P., and S. A. Cohen. 1991. Endogenous interferon α/B produced by Kupffer cells inhibits interleukin-1. tumor necrosis factor α production and interleukin-2-induced activation of nonparenchymal cells. Cancer Immunol. Immunother. 34:150.
23. M1 positive liver cells from athymic nude or polyinosinic-polycytidylic acid-treated mice in suppressing colon-derived experimental hepatic metastasis. Cancer Res. 50:13-1.
24. Verbik D. J., T. G. Murray, J. M. Tran, and B. R. Ksander. 1997. Melanomas that develop within the eye inhibit lymphocyte proliferation. Int. J. Cancer 73:470.
25. Kan-Mitchell J., M. S. Mitchell, N. Rao, and P. E. Liggett. 1989. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest. Ophthalmol. Vis. Sci. 30:829.
26. + cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol. Immunother. 38:399.
27. Luyten, G. P. M., C. M. Mooy, P. T. V. M. De Jong, A. T. Hoogeveen, and T. M. Luider 1993. A chicken embryo model to study the growth of human uveal melanoma. Biochem. Biophys. Res. Commun. 192:22.
28. De Waard-Siebinga, I., D. J. Blom, M. Greffioen, P. I. Schrier, E. Hoogendoorn, G. Beverstock, E. H Danen, and M. J. Jager. 1995. Establishment and characterization of an uveal melanoma cell line. Int. J. Cancer 62:155.
29. Bloom, B. R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80.
30. Koo, G. C., F. J. Dumont, M. Tutt, J. Hackett, Jr., and V. Kumar. 1986. The NK-1.1 (-) mouse: a model to study differentiation of murine NK cells. J. Immunol. 137:3742.
31. Murphy, W. J., Kumar, V., and M. Bennett. 1990. Natural killer cells activated by interleukin-2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen specific hone marrow rejection in vivo. Eur. J. Immunol. 20:1729.
32. M1. J. Immunol. 131:2101.
33. Blom, D. J., G. P. Luyten, C. Mooy, S. Kerkvliet, A. H. Zwinderman, and M. J. Jager. 1997. Human leukocyte antigen class 1 expression: marker of poor prognosis in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 38:1865.
34. Nishibori, M., N. Nakaya, A. Tahara, M. Kawabata, S. Mori, and K. Saeki. 1996. Presence of macrophage migration inhibitory factor (MIF) in ependyma, astrocytes and neurons in the bovine brain. Neuroisci. Lett. 213:193.
35. Imamura, K., J. Nishihira, M. Suzuki, K. Yasuda, S. Sasaki, Y. Kusunoki, H. Tochimaru, and Y. Takekoshi. 1996. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney, Biochem. Mol. Biol. Int. 40:1233.
36. Shimizu, T., A. Ohkawara, J. Nishihira, and W. Sakamoto. 1996. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett. 381:199.
37. Suzuki, H., H. Kanagawa, and J. Nishihira. 1996. Evidence for the presence of macrophage migration inhibitory factor in murine reproductive organs and early embryos. Immunol. Lett. 51:141.
38. Bernhagen, J., R. A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33:14144.
39. Rook, A. H., J. H. Kehrl, L. M. Wakefield, A. B. Roberts, M. B. Sporn, D. B. Burlington, H. C. Lane, and A. S. Fauci. 1986. Effects of transforming growth factor B on the function of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:3916.
40. Malefyt, R. W., H. Yssel, M. Roncarolo, H. Spits, and J. E. Vries. 1992. Interleukin-10. Curr. Opin. Immunol. 4:314.
41. Meyer-Siegler, K., and P. B. Hudson. 1996. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology 48: 448.
42. Shimizu, T., Ohkawara, A., Nishihira, J., and W. Sakamoto. 1996. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett. 381:199.